Literature DB >> 9028690

Cognitive function in younger type II diabetes.

J Dey1, A Misra, N G Desai, A K Mahapatra, M V Padma.   

Abstract

OBJECTIVE: To examine central nervous system involvement as a possible complication of diabetes by performing a comprehensive neuropsychological evaluation of relatively young (age < 55 years) NIDDM patients and a group of control subjects. RESEARCH DESIGN AND METHODS: A cross-sectional comparative study of 28 patients, with duration of diabetes 5-18 years (mean +/- SD +/- 3.2 years), screened for acceptable glycemic control and absence of hypoglycemia on the day of examination, compared with 28 demographically similar, nondiabetic control subjects. Neuropsychometric tests performed were Mini-Mental Status Examination (MMSE), Neurobehavioral Cognitive Status Examination (NCSE), and P300 latencies (endogenous evoked potentials).
RESULTS: Seven (25.0%) patients reported history suggestive of cognitive impairment during day-to-day activities, and 17 (60.7%) had distal symmetrical polyneuropathy. Average P300 latencies were significantly delayed among the diabetic patients compared with the control subjects (349.5 +/- 28.2 vs. 312.9 +/- 19.3 ms; t = 5.68, P < 0.001). Although there was no significant difference in MMSE scores, compared with control subjects significantly more patients had impairment in NCSE tests of attention (chi 2 = 7.38, P < 0.01), repetition (chi 2 = 4.073, P < 0.05), and memory (chi 2 = 5.83, P < 0.05), while there was no significant difference in tests of comprehension, naming, construction, and calculation. Duration of diabetes, HbA1c levels, and the presence of distal symmetrical polyneuropathy among patients each did not correlate with any of the parameters of cognitive function evaluated. Higher blood glucose levels during the electrophysiological testing were associated with less delay in P300 latencies among the patients.
CONCLUSIONS: Central nervous system impairment, manifesting as mild impairments in certain cognitive skills, should be recognized as a possible complication of long-standing NIDDM, even in relatively younger individuals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028690     DOI: 10.2337/diacare.20.1.32

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

1.  Effects of hypertension and diabetes on sentence comprehension in aging.

Authors:  Dalia Cahana-Amitay; Martin L Albert; Emmanuel A Ojo; Jesse Sayers; Mira Goral; Loraine K Obler; Avron Spiro
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2012-10-09       Impact factor: 4.077

Review 2.  Current status of clinical and experimental researches on cognitive impairment in diabetes.

Authors:  Xiao-chun Liang; Sai-shan Guo; Nobuyoshi Hagino
Journal:  Chin J Integr Med       Date:  2006-03       Impact factor: 1.978

3.  A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus.

Authors:  E van den Berg; Y D Reijmer; J de Bresser; R P C Kessels; L J Kappelle; G J Biessels
Journal:  Diabetologia       Date:  2009-10-31       Impact factor: 10.122

4.  Hyperactivation of working memory-related brain circuits in newly diagnosed middle-aged type 2 diabetics.

Authors:  Xiao-Song He; Zhao-Xin Wang; You-Zhi Zhu; Nan Wang; Xiaoping Hu; Da-Ren Zhang; De-Fa Zhu; Jiang-Ning Zhou
Journal:  Acta Diabetol       Date:  2014-07-04       Impact factor: 4.280

5.  Covert hepatic encephalopathy: does the mini-mental state examination help?

Authors:  Michela Corrias; Matteo Turco; Michele D Rui; Angelo Gatta; Paolo Angeli; Carlo Merkel; Piero Amodio; Sami Schiff; Sara Montagnese
Journal:  J Clin Exp Hepatol       Date:  2014-01-24

6.  Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats.

Authors:  Remya Robinson; Amee Krishnakumar; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2009-01-09       Impact factor: 5.046

7.  A comparative study of reaction times between type II diabetics and non-diabetics.

Authors:  Samantha J Richerson; Charles J Robinson; Judy Shum
Journal:  Biomed Eng Online       Date:  2005-02-21       Impact factor: 2.819

Review 8.  Does Intensive Glucose Control Prevent Cognitive Decline in Diabetes? A Meta-Analysis.

Authors:  Carlos Peñaherrera-Oviedo; Daniel Moreno-Zambrano; Michael Palacios; María Carolina Duarte-Martinez; Carlos Cevallos; Ximena Gamboa; María Beatriz Jurado; Leonardo Tamariz; Ana Palacio; Rocío Santibañez
Journal:  Int J Chronic Dis       Date:  2015-08-04

Review 9.  A look inside the diabetic brain: Contributors to diabetes-induced brain aging.

Authors:  Shayna A Wrighten; Gerardo G Piroli; Claudia A Grillo; Lawrence P Reagan
Journal:  Biochim Biophys Acta       Date:  2008-11-05

Review 10.  The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.

Authors:  Anders A F Sima; Weixian Zhang; Zhen-guo Li; Hideki Kamiya
Journal:  Exp Diabetes Res       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.